| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |